Biosimilars Therapeutic proteins (biosimilars) manufactured from natural sources and providing solutions for several unmet clinical needs are the next big thing in India. Adoption, growing investment and deal making in the global arena has got several Indian companies tuning in to biosimilars, reports The Pharma Letter’s India correspondent. 31 October 2016